Bayforest Capital’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273K Sell
1,151
-190
-14% -$39.5K 0.25% 85
2026
Q1
$283K Sell
1,341
-1,459
-52% -$314K 0.32% 46
2025
Q4
$575K Sell
2,800
-2,328
-45% -$438K 0.43% 16
2025
Q3
$805K Buy
5,128
+2,295
+81% +$355K 0.38% 35
2025
Q2
$476K Buy
+2,833
New +$420K 0.21% 192

Other funds holding CAH

Bayforest Capital's CAH Position: Q2 2026 in Review

Bayforest Capital reduced its Cardinal Health (CAH) stake by 14% in Q2 2026, selling an estimated $39.5K and leaving 1,151 shares worth $273K. The position accounts for 0.25% of the portfolio, ranked #85.

Bayforest Capital first reported a position in CAH in Q2 2025 and has held it in 5 quarters since. The position peaked at $805K in Q3 2025. 1,492 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Bayforest Capital held 1,151 shares of Cardinal Health worth $273K as of Q2 2026.
  • Bayforest Capital sold 190 Cardinal Health shares in Q2 2026, an estimated $39.5K.
  • Cardinal Health made up 0.25% of Bayforest Capital's portfolio in Q2 2026, its #85 holding.
  • Bayforest Capital first reported a position in Cardinal Health in Q2 2025 and has held it in 5 quarters since.
  • Bayforest Capital's Cardinal Health position peaked at $805K in Q3 2025.
  • 1,492 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.